Journal article icon

Journal article

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.

Abstract:
The anti-influenza drug oseltamivir is an ester prodrug activated by hepatic carboxylesterases. Plasma esterases also convert up to 31.8% of the parent compound to the active metabolite after 4 h ex vivo, with wide interindividual variation. This source of error is removed by adding the esterase inhibitor dichlorvos to blood collection tubes.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1128/aac.00500-06

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author


Journal:
Antimicrobial agents and chemotherapy More from this journal
Volume:
50
Issue:
9
Pages:
3197-3199
Publication date:
2006-09-01
DOI:
EISSN:
1098-6596
ISSN:
0066-4804


Language:
English
Keywords:
Pubs id:
pubs:27915
UUID:
uuid:4ad0f9ea-adf1-4b88-b8b6-89143f5e682d
Local pid:
pubs:27915
Source identifiers:
27915
Deposit date:
2012-12-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP